Latest Articles

  • Cannabis for peripheral neuropathy: The good, the bad, and the unknown
    Vania Modesto-Lowe, MD, MPH, Rachel Bojka, MS, PA-C and Camille Alvarado, DO, MPH
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 943-949; DOI: https://doi.org/10.3949/ccjm.85a.17115

    Even where it is legal, doctors should recommend it only after careful consideration.

  • Narcolepsy: Diagnosis and management
    Erin C. Golden, MD and Melissa C. Lipford, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 959-969; DOI: https://doi.org/10.3949/ccjm.85a.17086

    Treatments can offer enhanced quality of life.

  • Cannabis for chronic pain: Not a simple solution
    Xavier F. Jimenez, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 950-952; DOI: https://doi.org/10.3949/ccjm.85a.18089

    Real concerns include amotivation, worsening psychiatric states, chronic disability, and chemical dependence.

  • Acute necrotizing esophagitis
    Takeshi Kondo, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 912-913; DOI: https://doi.org/10.3949/ccjm.85a.18054

    Poorly controlled diabetes, confusion, coffee-ground emesis.

  • Men’s health 2018 (November 2018)
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 913;

    An error occurred in Chaitoff A, Killeen TC, Nielsen C. Men’s health 2018: BPH, prostate cancer, erectile dysfunction, supplements. Cleve Clin J Med 2018; 85(11):871–880. doi:10.3949/ccjm.85a.18011.

  • A new reason to reconsider that antibiotic prescription: The microbiome
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 906-907; DOI: https://doi.org/10.3949/ccjm.85b.12018

    Prescribing an antibiotic is a far more complicated and long-lasting affair than most of us thought.

  • What can I do when first-line measures are not enough for vasovagal syncope?
    Erika Hutt-Centeno, MD and Kenneth A. Mayuga, MD, FHRS, FACC, FACP
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 920-922; DOI: https://doi.org/10.3949/ccjm.85a.17112

    Second-line measures include midodrine, fludrocortisone, beta-blockers, and SSRIs, but evidence is limited.

  • Telemedicine: Past, present, and future
    Jamal H. Mahar, MD, Gregory J. Rosencrance, MD and Peter A. Rasmussen, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 938-942; DOI: https://doi.org/10.3949/ccjm.85a.17062

    Low reimbursement, licensing, practice issues limit its use.

  • Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Kathryn Bux Rodeman, MD and Betul Hatipoglu, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 931-937; DOI: https://doi.org/10.3949/ccjm.85a.17088

    Chief among the challenges: millions of people have diabetes.

  • Our missing microbes: Short-term antibiotic courses have long-term consequences
    Martin J. Blaser, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 928-930; DOI: https://doi.org/10.3949/ccjm.85gr.18005

    Is the rise in chronic diseases due to loss of microbial diversity?

Pages